He hoped to sell higher volumes of obesity and diabetes drugs over the coming years, saying: We are seeing a volume response to lower prices. He pointed to Novos agreement with the Trump administration to cut prices heavily, from more than $1,000 a month (730) to an average price of $350 (255), and the patent expiry of semaglutide, the main ingredient of its obesity and diabetes drugs, in several countries including India
BMJ 388:e080679
The GLP-1 Daily Support supplement includes ingredients like alpha lipoic acid, berberine, chromium, and a multivitamin blend to maintain nutritional balance
10.1038/s41598-019-55524-w 9 ChibaY.YamadaT.TsukitaS.TakahashiK.MunakataY.ShiraiY.et al (2016)
There is the worry that lost weight may be regained when the jabs are stopped and that the drugs do not tackle the root cause of obesity
Other options include herbal remedies such as ginger or peppermint